# Eculizumab Dosing Intervals Longer than 17 Days May Be Associated with Greater Risk of Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/eculizumab-dosing-intervals-longer-than-17-days-may-be-associated-with-greater/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hirokazu Nakayama,Kensuke Usuki,Hirotoshi Echizen,Ryuichi Ogawa,Takao Orii |
| Citations | 44 |
| DOI | 10.1248/bpb.b15-00703 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.jstage.jst.go.jp/article/bpb/39/2/39_b15-00703/_pdf |
| OpenAlex ID | https://openalex.org/W2340385532 |
| PMID | 26830487 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Hirokazu Nakayama](https://scholariq.org/researchers/hirokazu-nakayama/)
- [Ryuichi Ogawa](https://scholariq.org/researchers/ryuichi-ogawa/)
- [Kensuke Usuki](https://scholariq.org/researchers/kensuke-usuki/)
- [Hirotoshi Echizen](https://scholariq.org/researchers/hirotoshi-echizen/)
- [Takao Orii](https://scholariq.org/researchers/takao-orii/)

## Paper journal

- [Biological and Pharmaceutical Bulletin](https://scholariq.org/journals/biological-and-pharmaceutical-bulletin/)

## Paper primary topic

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Paper topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.